CalciMedica, Inc. financial data

Symbol
CALC on Nasdaq
Industry
Pharmaceutical Preparations
Location
505 Coast Boulevard South, Suite 307, La Jolla, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
CalciMedica, Inc. /DE/ (to 3/22/2023), GRAYBUG VISION, INC. (to 3/15/2023), GRAYBUG, Inc. (to 5/13/2016), GRAYBUG LLC (to 10/7/2014)
Latest financial report
10-K - Q4 2024 - Mar 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 526 % +57.5%
Debt-to-equity 54.4 % +30.6%
Return On Equity -101 % +57.2%
Return On Assets -65.1 % +60.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13.5M shares +25.5%
Common Stock, Shares, Outstanding 13.5M shares +134%
Entity Public Float 27.9M USD +138%
Common Stock, Value, Issued 4K USD +300%
Weighted Average Number of Shares Outstanding, Basic 11.2M shares +151%
Weighted Average Number of Shares Outstanding, Diluted 11.2M shares +151%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 14.5M USD -8.71%
General and Administrative Expense 9.73M USD -56.2%
Operating Income (Loss) -24.2M USD +36.4%
Nonoperating Income (Expense) 10.5M USD +183%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -13.7M USD +60.1%
Earnings Per Share, Basic -1.22 USD/shares +84.1%
Earnings Per Share, Diluted -1.22 USD/shares +84.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.94M USD +43.5%
Cash, Cash Equivalents, and Short-term Investments 18.7M USD +67%
Assets, Current 19.7M USD +69.5%
Property, Plant and Equipment, Net 119K USD -28.7%
Operating Lease, Right-of-Use Asset 0 USD -100%
Assets 19.8M USD +62.4%
Accounts Payable, Current 2M USD +40.8%
Employee-related Liabilities, Current 758K USD -6.77%
Liabilities, Current 3.68M USD -8.54%
Liabilities 5.38M USD +33.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 4K USD +100%
Retained Earnings (Accumulated Deficit) -160M USD -9.38%
Stockholders' Equity Attributable to Parent 14.4M USD +76.7%
Liabilities and Equity 19.8M USD +62.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.72M USD +12%
Net Cash Provided by (Used in) Financing Activities 19M USD -19%
Net Cash Provided by (Used in) Investing Activities -13.1M USD -376%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 13.5M shares +134%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.23M USD -94.7%
Deferred Tax Assets, Valuation Allowance 88.5M USD +7.13%
Deferred Tax Assets, Gross 88.5M USD +7.12%
Operating Lease, Liability 117K USD -76.2%
Depreciation 58K USD 0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -13.7M USD +60.1%
Lessee, Operating Lease, Liability, to be Paid 118K USD -76.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1K USD -94.1%
Deferred Tax Assets, Operating Loss Carryforwards 62.4M USD +6.62%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 11.5M USD +3.63%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 13K USD 0%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 118K USD
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 12M USD +759%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%